NCT07676565Recruiting
Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study
Safety and Efficacy of Adjunct Therapies in Adults With Type 1diabetes: Multicenter, Registry Study
Source: ClinicalTrials.gov · Last updated 16 Oct 2026
Brief summary (registry, in English)
This will be a multicenter registry-based study to evaluate safety and efficacy of GLP-1RA and SGLTi therapies in adjunct to insulin in adults with type 1 diabetes (T1D) over 1 year. This study will enroll participants who have been prescribed adjunct therapy as part of usual care.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 24 Jun 2026
- Start date
- 24 Mar 2026
- Primary completion date
- 30 Apr 2028
- Lead sponsor
- Indiana University
- Diseases
- Type 1 diabetes
- NCT number
- NCT07676565
What you commit to
- Study type: Observational
- Planned participants: 300
- From 24 Mar 2026 to the primary completion date, 30 Apr 2028
- 17 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- No exclusion criteria other than those not meeting inclusion criteria above
Who the study is looking for
- Adults ≥18 years of age
- Clinical diagnosis of T1D
- GLP-1RA or SGLTi (SGLT-1 and SGLT-2 inhibitors) drug prescribed by their provider for any indication as part of usual care with use for no more than 1 week
- Use of CGM and availability of CGM data for 1 month prior to enrollment and expected to be available throughout the study
- Willing and able to provide informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (17)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Emory University Coordinator of this site? Confirm its status | Atlanta | United States | Recruiting |
| Harvard Medical School Coordinator of this site? Confirm its status | Boston | United States | Recruiting |
| Northwestern University Coordinator of this site? Confirm its status | Chicago | United States | Recruiting |
| University of Cincinnati Coordinator of this site? Confirm its status | Cincinnati | United States | Recruiting |
| Ohio State University Coordinator of this site? Confirm its status | Columbus | United States | Recruiting |
| Henry Ford Hospital Coordinator of this site? Confirm its status | Detroit | United States | Recruiting |
| University of Louisville Coordinator of this site? Confirm its status | Louisville | United States | Recruiting |
| University of Miami Coordinator of this site? Confirm its status | Miami | United States | Recruiting |
| HealthPartners, International Diabetes Center Coordinator of this site? Confirm its status | Minneapolis | United States | Recruiting |
| Hoag Memorial Hospital Coordinator of this site? Confirm its status | Newport Beach | United States | Recruiting |
| Mount Sinai Coordinator of this site? Confirm its status | New York | United States | Recruiting |
| NYU Grossman School of Medicine Coordinator of this site? Confirm its status | New York | United States | Recruiting |
| Eastern Virginia Medical Center, Old Dominion University Coordinator of this site? Confirm its status | Norfolk | United States | Recruiting |
| University of Nebraska Medical Center Coordinator of this site? Confirm its status | Omaha | United States | Recruiting |
| Maine Health Research Institute Coordinator of this site? Confirm its status | Portland | United States | Recruiting |
| University of Rochester Coordinator of this site? Confirm its status | Rochester | United States | Recruiting |
| University of California, San Francisco (UCSF) Coordinator of this site? Confirm its status | San Francisco | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.